---
ver: rpa2
title: A Multimodal Vision Foundation Model for Clinical Dermatology
arxiv_id: '2410.15038'
source_url: https://arxiv.org/abs/2410.15038
tags:
- panderm
- data
- skin
- images
- dataset
- transformers
- self-attention
- retrieval-augmented-generation
- instruction-tuning
- parameter-efficient-finetuning
- mixture-of-experts
- chain-of-thought
core_contribution: PanDerm is a multimodal foundation model for clinical dermatology
  that addresses the limitations of existing AI models by integrating diverse imaging
  modalities and workflows. The model was pretrained on over 2 million unlabeled skin
  disease images from 11 institutions across 4 imaging modalities using self-supervised
  learning with masked latent modeling and CLIP-based feature alignment.
---

# A Multimodal Vision Foundation Model for Clinical Dermatology

## Quick Facts
- arXiv ID: 2410.15038
- Source URL: https://arxiv.org/abs/2410.15038
- Reference count: 40
- A multimodal foundation model for clinical dermatology that achieved state-of-the-art performance across 28 clinical benchmarks while requiring only 10% of labeled data compared to existing models.

## Executive Summary
PanDerm addresses the limitations of existing AI models in clinical dermatology by developing a multimodal foundation model that integrates diverse imaging modalities and workflows. The model was pretrained on over 2 million unlabeled skin disease images from 11 institutions across 4 imaging modalities using self-supervised learning. It achieved state-of-the-art performance across 28 clinical benchmarks, often outperforming existing models while requiring significantly less labeled data. In reader studies, PanDerm improved clinicians' diagnostic accuracy by up to 11% for skin cancer diagnosis and enhanced non-dermatologist healthcare providers' differential diagnosis by 16.5% across 128 skin conditions.

## Method Summary
PanDerm uses a self-supervised learning approach with masked latent modeling and CLIP-based feature alignment to pretrain on over 2 million unlabeled skin disease images across 4 imaging modalities. The architecture employs a ViT-Large encoder, mask regressor, and CLIP-Large teacher model, trained for 500 epochs with 50% mask ratio. The model was evaluated across 28 clinical benchmarks including skin cancer screening, risk stratification, differential diagnosis, lesion segmentation, longitudinal monitoring, and metastasis prediction. Performance was validated through three reader studies comparing clinician performance with and without PanDerm assistance.

## Key Results
- Achieved state-of-the-art performance across 28 clinical benchmarks
- Outperformed existing models while requiring only 10% of labeled data
- Improved clinicians' diagnostic accuracy by up to 11% for skin cancer diagnosis
- Enhanced non-dermatologist healthcare providers' differential diagnosis by 16.5% across 128 skin conditions

## Why This Works (Mechanism)
PanDerm leverages self-supervised learning with masked latent modeling to learn rich, generalizable representations from unlabeled data across multiple imaging modalities. The CLIP-based feature alignment ensures consistent feature representations across different imaging modalities (dermoscopic, clinical, TBP tiles, dermatopathology), enabling the model to transfer knowledge effectively between tasks. This multimodal pretraining approach allows the model to develop robust representations that generalize well to diverse clinical scenarios while requiring minimal labeled data for downstream tasks.

## Foundational Learning
- **Masked Latent Modeling**: A self-supervised learning technique where random portions of input are masked and the model learns to reconstruct them - needed for learning robust representations without labels; quick check: verify pretraining reconstruction loss decreases over epochs
- **CLIP-based Feature Alignment**: Uses contrastive learning to align features across different modalities - needed for consistent representation across dermoscopic, clinical, and pathology images; quick check: measure feature similarity between modalities using linear probes
- **Multimodal Integration**: Combining different imaging modalities (dermoscopic, clinical, TBP tiles, dermatopathology) - needed for comprehensive dermatological assessment; quick check: evaluate performance drop when individual modalities are excluded

## Architecture Onboarding

**Component Map:**
Pretraining Dataset -> Masked Latent Modeling + CLIP Alignment -> ViT-Large Encoder -> Mask Regressor & CLIP-Large Teacher -> PanDerm Foundation Model

**Critical Path:**
Pretraining (500 epochs, 50% mask ratio) -> Feature Alignment -> Downstream Task Fine-tuning -> Clinical Evaluation

**Design Tradeoffs:**
- ViT-Large vs. smaller architectures: Larger model provides better performance but requires more computational resources
- 50% mask ratio: Higher masking improves generalization but may slow convergence
- CLIP-based alignment vs. modality-specific encoders: Alignment provides consistent features but may lose modality-specific details

**Failure Signatures:**
- Training instability: Monitor gradient norms and learning rate schedules
- Poor downstream performance: Check pretraining loss curves and feature similarity across modalities
- Mode collapse: Evaluate diversity of learned representations across different skin conditions

**3 First Experiments:**
1. Evaluate pretraining reconstruction loss and feature similarity across modalities using linear probing on held-out tasks
2. Test downstream performance on a simple classification task (e.g., benign vs. malignant) with varying amounts of labeled data
3. Assess model robustness by testing performance on low-quality or partially obscured images

## Open Questions the Paper Calls Out

**Open Question 1:**
How does PanDerm's performance on rare dermatological conditions compare to more common ones, and what is the model's performance ceiling on extremely rare diseases? The paper acknowledges that their evaluation covers approximately 200 skin conditions, representing only a fraction of known dermatological conditions (over 1,000 diagnoses), with specific mention that coverage of rare genetic disorders, complex systemic diseases, and clinical variants remains limited.

**Open Question 2:**
What are the specific biases in PanDerm's performance across different skin tones, and how do these biases manifest in human-AI collaborative settings? While the paper demonstrates consistent performance across different settings (anatomical locations, age groups, genders, and skin tones), it acknowledges that comprehensive bias assessment requires metrics beyond overall accuracy and that equitable standalone performance may not translate to unbiased human-AI collaboration.

**Open Question 3:**
How does PanDerm's performance scale with additional training data beyond 2 million images, and what are the theoretical limits of its performance improvements? The paper discusses scaling behavior in relation to pretraining dataset size but only tested up to 1.8 million images in its scaling analysis, leaving questions about performance with larger datasets and potential diminishing returns.

## Limitations
- Pretraining dataset may not fully represent all demographic variations and rare skin conditions
- Computational requirements for ViT-Large architecture may limit accessibility for smaller healthcare institutions
- Performance improvements in reader studies need independent validation across different healthcare systems and clinician populations

## Confidence

**High:** Technical implementation and benchmark results, given rigorous experimental design and comparison with established baselines

**Medium:** Clinical impact claims, as reader study results need replication across different populations and clinical settings

**Low:** Long-term performance stability, as behavior with new, previously unseen skin conditions or imaging modalities has not been fully characterized

## Next Checks

1. Conduct multi-center validation studies across different healthcare systems and demographic populations to verify reported performance improvements hold consistently across diverse clinical settings.

2. Perform ablation studies specifically examining the contribution of each imaging modality to overall performance, to better understand optimal modality combinations for different clinical tasks.

3. Test model performance with low-quality or partially obscured images that might occur in real-world clinical settings, to assess robustness to common imaging variations and artifacts.